ERAS 8-K: SEC filing
Erasca, Inc.
Filed with the SEC on · accession 0001193125-26-458350
ERAS filed a 8-K (current report) with the SEC on Nov 12, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The stock moved -6.1% by the first close after the filing.
Summary of the filing
Erasca, Inc. announced its financial results for the three months ended September 30, 2026, via a press release furnished as Exhibit 99.1 to this Form 8-K.
Key details
How ERAS stock reacted
Close before
$16.80
Nov 11, 2026
First close after
-6.07%
$15.78
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for ERAS, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ERAS?
Click hereFrequently asked questions
What did ERAS file with the SEC on Nov 12, 2026?
ERAS filed a 8-K (SEC filing). Erasca, Inc. announced its financial results for the three months ended September 30, 2026, via a press release furnished as Exhibit 99.1 to this Form 8-K.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
How did ERAS stock react to this filing?
ERAS closed at $16.80 before the filing and $15.78 on Nov 12, 2026 (-6.07%).
Other ERAS SEC filings
- 10-Q · SEC filingNov 12, 2026
- 8-K · Executive departureOct 16, 2026
- 8-K · SEC filingAug 24, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- 10-Q · SEC filingAug 11, 2026
- 8-K · SEC filingAug 11, 2026
- 8-K · Executive departureAug 10, 2026
- 424B5 · Secondary offeringJul 14, 2026
- 8-K · Secondary offeringJul 14, 2026
- 8-K · Fda approvalJul 13, 2026
Get alerts when ERAS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days